Meeting
2022 ASCO Genitourinary Cancers Symposium
Does presence of diabetes mellitus impact patient oncological outcomes in renal cell carcinoma: A multicenter analysis.
Authors
Ava Saidian
University of California San Diego, Moores Cancer Center, La Jolla, CA
Ava Saidian , Arman Walia , Dattatraya Patil , Kazutaka Saito , Devin Patel , Mimi Vu Nguyen , Madison Chakoumakos , Fady Ghali , Rekha S Narasimhan , John M Perry , Margaret Meagher , Yosuke Yasuda , Yasuhisa Fujii , Viraj A. Master
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 325)
DOI
10.1200/JCO.2022.40.6_suppl.325
Abstract #
325
Poster Bd #
E12
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study.
First Author: Raksha Dutt
Poster
2019 Genitourinary Cancers Symposium
Proposal for tripartite re-classification of T1 renal cell carcinoma into cT1a (very low risk), cT1b (low risk), and cT1c (intermediate risk) substages.
First Author: Aaron Bradshaw
Poster
2024 ASCO Annual Meeting
Impact of boarding time on in-hospital mortality in patients with cancer presenting to the emergency department.
First Author: Patricia A. Brock
Poster
2024 ASCO Genitourinary Cancers Symposium
Risk of early non-cancer deaths in adults diagnosed with metastatic genitourinary (mGU) cancers: A retrospective cohort study.
First Author: Ahsan Ayaz